The FDA's War Against the Truth on Ivermectin
It’s important to address two criticisms of our work. The first is that we exaggerated the FDA’s warning on ivermectin. The second is that Merck’s stance on ivermectin proved that even the company that developed ivermectin thought that it doesn’t work for Covid-19.
First, we didn’t exaggerate the FDA’s warning on ivermectin. Instead, the agency changed its website after our article was published, probably to reflect the points we made. Second, Merck had two incentives to downplay ivermectin’s usefulness against the novel coronavirus. We’ll explain both points more fully.
This is from Charles L. Hooper and David R. Henderson, “The FDA’s War Against the Truth on Ivermectin,” American Institute for Economic Research, October 18, 2021.
Read the whole thing.